These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18780336)
1. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect. Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504 [TBL] [Abstract][Full Text] [Related]
3. Hepatic and intestinal first-pass effects of oltipraz in rats. Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718 [TBL] [Abstract][Full Text] [Related]
4. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. Choi YH; Kim SG; Lee MG J Pharm Sci; 2006 Nov; 95(11):2543-52. PubMed ID: 16937336 [TBL] [Abstract][Full Text] [Related]
5. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects. Han KS; Lee MG Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506 [TBL] [Abstract][Full Text] [Related]
7. Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect. Kim EJ; Bae SK; Kim HJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG J Pharm Sci; 2003 May; 92(5):1112-24. PubMed ID: 12712431 [TBL] [Abstract][Full Text] [Related]
8. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability. Yang SH; Lee MG Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458 [TBL] [Abstract][Full Text] [Related]
9. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect. Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246 [TBL] [Abstract][Full Text] [Related]
10. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Yang SH; Lee MG Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability. Lee JH; Lee MG J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects. Kim SH; Lee MG Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect. Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects. Shin HS; Bae SK; Lee MG Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacokinetics of oral amitriptyline and its active metabolite nortriptyline in fed and fasted Greyhound dogs. Norkus C; Rankin D; KuKanich B J Vet Pharmacol Ther; 2015 Dec; 38(6):619-22. PubMed ID: 25989225 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs. Norkus C; Rankin D; KuKanich B Vet Anaesth Analg; 2015 Nov; 42(6):580-9. PubMed ID: 25683584 [TBL] [Abstract][Full Text] [Related]
17. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Liu YT; Hao HP; Xie HG; Lai L; Wang Q; Liu CX; Wang GJ Drug Metab Dispos; 2010 Oct; 38(10):1779-84. PubMed ID: 20634337 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats. Han KS; Kim YG; Yoo JK; Lee JW; Lee MG Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol. Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of amitriptyline and its demethylated metabolite in serum and brain of rats after acute and chronic oral administration of amitriptyline. Miyake K; Fukuchi H; Kitaura T; Kimura M; Kimura Y J Pharmacobiodyn; 1992 Apr; 15(4):157-66. PubMed ID: 1494978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]